The deal size was increased to $420M from $350M and to 6.77M shares offered from 6.0M, pricing below last closing price of $65.24. Jefferies, BofA, Goldman Sachs, TD Cowen and Stifel are acting as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on APGE:
- Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
- Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
- Apogee Therapeutics announces $350M common stock offering
- Apogee Therapeutics files to sell 6M shares of common stock
- Apogee Therapeutics price target raised to $95 from $46 at Stifel
